LENSAR (LNSR) H.C. Wainwright 26th Annual Global Investment Conference 2024 summary
Event summary combining transcript, slides, and related documents.
H.C. Wainwright 26th Annual Global Investment Conference 2024 summary
21 Jan, 2026Market opportunity and technology leadership
Estimated 32 million cataract procedures in 2024, but only 1 million use laser-assisted methods.
ALLY system combines advanced imaging and dual-pulse laser for single-step, sterile procedures.
ALLY is the first to use AI with iris registration for astigmatism correction.
80 ALLY systems placed as of June 30, 2024, with 17 more pending installation.
Regulatory approvals and first shipments completed in the EU and Southeast Asia.
Efficiency, workflow, and clinical outcomes
ALLY offers the fastest laser-assisted cataract procedure, saving significant time for surgeons and staff.
Smallest footprint, wireless integration, and enhanced workflow reduce staff interactions and errors.
AI-driven astigmatism management eliminates manual data entry and improves outcomes.
Proprietary imaging ensures precise lens positioning and faster visual recovery.
Superior outcomes: 98% of patients within half a diopter of target, over 95% for arcuate incisions.
Financial impact and business value
ALLY drives $400,000–$500,000 in annual cost savings for ASCs and up to $500,000 in additional revenue per surgeon.
Saves 90–120 minutes per surgery day, enabling more procedures and higher profitability.
ALLY users saw a fivefold increase in conversion rates and $750,000 in added revenue over eight months.
44.3% gain in U.S. procedure market share since ALLY's launch.
16% increase in U.S. and 19% worldwide procedure volume in Q2 2022 vs. 2023.
Latest events from LENSAR
- Q2 2026 delivered 18% revenue growth, record profitability, and strong recurring revenue.LNSR
Q2 2026 - Directors re-elected, auditor ratified, and annual advisory votes on compensation approved.LNSR
AGM 2026 - Annual meeting to vote on directors, auditor, and executive pay, with board support for all.LNSR
Proxy filing - Annual meeting to vote on directors, auditor, executive pay, and say-on-pay frequency, with strong governance.LNSR
Proxy filing - Robotic laser system accelerates growth, efficiency, and outcomes in cataract surgery.LNSR
Corporate presentation - Recurring revenue rose 9% to 94% of total as net income rebounded on one-time gains.LNSR
Q1 2026 - Recurring revenue rose 15% in 2025, with ALLY installations up 48% and net loss sharply reduced.LNSR
Q4 2025 - Q3 2024 revenue up 38% to $13.5M, with ALLY growth and positive Adjusted EBITDA despite ongoing risks.LNSR
Q3 2024 - Record Q2 revenue and ALLY placements, global expansion, and break-even adjusted EBITDA.LNSR
Q2 2024